HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative clinical examination of Loderix (setastinum) and astemizole in pollenosis.

Abstract
The action and side-effects of Loderix (EGIS) were examined in comparison with Hismanal (Janssen) containing the non-sedative H1-receptor antagonist astemizole, by double-blind, cross-over, self-controlled method. On the basis of the changes observed in response to the two drugs in the symptoms of rhinoconjunctivitis and asthma of 21 patients suffering from pollenosis Loderix proved to be of the same value as Hismanal considering both clinical effectivity and side-effects.
AuthorsI Herjavecz, E Karácsonyi, S Mülbacher, K Radics, R Szilágyi, I Gacsályi
JournalTherapia Hungarica (English edition) (Ther Hung) Vol. 41 Issue 4 Pg. 141-5 ( 1993) ISSN: 0133-3909 [Print] Hungary
PMID8029782 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Azepines
  • setastine
  • Astemizole
Topics
  • Adult
  • Astemizole (therapeutic use)
  • Azepines (therapeutic use)
  • Double-Blind Method
  • Female
  • Forced Expiratory Volume
  • Humans
  • Male
  • Radioallergosorbent Test
  • Rhinitis, Allergic, Seasonal (diagnosis, drug therapy, physiopathology)
  • Severity of Illness Index
  • Skin Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: